Key facts
- Gran Lab’s last known valuation is $3.3M (May 2025).
- It has raised $800K.
- Notable investors include Techstart Ventures, Female Founders, ICURe, Ideate Ireland, QUBIS — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Gran Lab
- ·The full record, as it builds
Funding rounds
No funding rounds for Gran Lab are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gran Lab
Operator of dermatological products intended to address chronic skin conditions without the use of steroids. The company's platform offers biochemistry-based formulations and products developed for diverse skin types, enabling individuals with skin conditions to manage symptoms and improve skin health.
- Sector
- Healthcare
- HQ
- Belfast, United Kingdom
- Employees
- 4
- Website
- granlab.co/
- Ownership
- Privately Held (backing)
Gran Lab doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gran Lab shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gran Lab in its N-PORT filings yet. We sweep new filings monthly.